Lung Cancer
An interventional open-label phase 1b/2 study to evaluate the safety, pharmacokinetics, and preliminary efficacy of PF-08634404 in combination with different anticancer agents in Participants with advanced solid tumors - C6461020
- Details
ClinicalTrials.gov ID:
NCT07227298
Diagnosis Type:
NA
USOR Number:
- Address
,
P: